The annual Digestive Disease Week, sponsored by the American Association for the Study of Liver Diseases, American Gastroenterological Association, American Society for Gastrointestinal Endoscopy, and Society for Surgery of the Alimentary Tract, was held from May 18 to 21 in San Diego. Two studies caught the attention of Today’s Practitioner:Read
Data shows a relationship between environmental toxicants and diabetes – so, what can you do to protect your patients? The first Global Report on Diabetes, recently published by the World Health Organization (WHO),[1] highlighted several alarming statistics: the incidence of diabetes has doubled since 1980, and as of 2012, itRead
Standardized pine bark extract (SPBE), also known as French maritime pine bark extract per its source of the Maritime pine (Pinus pinaster Aiton), offers anti-aging benefits that encompass structure, beauty, and function. A diverse array of clinical research backs the use of this supplement, with data showing it supports theRead
The Evidence Behind Natural Interventions for Non-alcoholic Fatty Liver Disease: Botanicals, Nutrients, and Probiotics for Treating This Common Ailment Given the rise in non-alcoholic fatty liver disease (NAFLD) in both adults and pediatrics and the lack of an indicated pharmaceutical treatment,[1],[2] natural strategies for the treatment of this condition standRead
Addressing a genetic issue & supporting cardiovascular health naturally. Cardiovascular health for many only becomes a concern with age, unless familial factors or birth defects highlight it earlier in life. Yet it isn’t uncommon that a higher profile story splashes the news, which reminds us that it may be somethingRead
Metabolic syndrome (MetSyn) is a multifaceted combination of cardiovascular disease risk factors and co-morbidities that include abdominal obesity, elevated triglycerides, mildly elevated blood pressure and fasting glucose, and low HDL-cholesterol. Disagreements remain as to whether MetSyn risk factors act synergistically or independently. However the alterations in plasma triglycerides (TG) andRead
Diabetes is five diseases, concludes a new study. By separating adult-onset diabetes cases into five different types, rather than just type 1 or type 2, physicians can better tailor early treatment for patients, and could represent a first step towards precision medicine in the disease, according to an analysis ofRead
With increasing rates of obesity and diabetes, the associated condition of nonalcoholic fatty liver disease (NAFLD) has become increasingly common, such that it is now the number one cause of liver disease in Western countries.[1] NAFLD affects 10 to 46% of the U.S. population, with a worldwide prevalence of 10Read
Stevia rebaudiana (SR), a popular calorie-free sweetener, may possess more health properties than originally thought, namely reducing the factors associated with metabolic syndrome. According to a new study, “Stevia rebaudiana Bertoni: A Natural Alternative for Treating Diseases Associated with Metabolic Syndrome,” published in the Journal of Medicinal Food, both in vitroRead
Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.
